Form4insider filings, from the source

SEC Form 4 · accession 0001126234-15-000043

NEWLINK GENETICS CORP · (NLNK)

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Nicholas N. Vahanian
Officer — President, Chief Medical Offic
Period of report
Mar 2, 2015
Accepted (ET)
Mar 4, 2015 · 6:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001126234

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3,F4,F5Mar 2, 2015S3,750$44.03D107,089D
Common StockF6,F4,F5Mar 2, 2015S5,000$45.14D102,089D
Common StockF7,F4,F5Mar 2, 2015S1,250$46.24D100,839D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses